4//SEC Filing
Feinberg Peter 4
Accession 0001790340-24-000028
CIK 0001790340other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:04 PM ET
Size
10.6 KB
Accession
0001790340-24-000028
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Feinberg Peter
Director
Transactions
- Purchase
Class A Common Stock
2024-03-18$2.31/sh+45,024$103,857→ 56,790 total - Purchase
Class A Common Stock
2024-03-18$3.05/sh+4,976$15,201→ 61,766 total - Purchase
Class A Common Stock
2024-03-19$2.56/sh+25,000$64,000→ 86,766 total
Holdings
- 476,615(indirect: By LLC)
Class A Common Stock
- 115,441(indirect: By LLC)
Class A Common Stock
- 392,242(indirect: General Partner of PF Associates L.P.)
Class A Common Stock
Footnotes (2)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.96 to $2.9499. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.9863 to $3.1799. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870076
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 7:04 PM ET
- Size
- 10.6 KB